Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03266536 · ClinicalTrials.gov registry record · NA
Small Bowel Microbiota Characterization in Healthy Individuals Before and After Consumption of a Western Diet
A NA study of Small Intestine Bacteria, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03266536: Completed NA study of Small Intestine Bacteria, sponsored by Mayo Clinic.
NCT03266536 is a NA study of Small Intestine Bacteria that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03266536, a NA study of Small Intestine Bacteria, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Does the small bowel microbiota in healthy individuals change after consumption of a Western diet?
Primary Outcome
DNA extraction from stool samples will be done using standard assays.
Conditions Studied
Interventions
- BEHAVIORAL Western diet
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-01-09 |
| Est. Completion | 2017-05-19 |
| Phase | NA |
What the finished NCT03266536 record still lists
NCT03266536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Small Intestine Bacteria appearing as the primary indexed condition, and to 1 intervention - of which Western diet is the first listed.
NCT03266536 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03266536 about?
NCT03266536 is a clinical study titled "Small Bowel Microbiota Characterization in Healthy Individuals Before and After Consumption of a Western Diet". Does the small bowel microbiota in healthy individuals change after consumption of a Western diet?
What is the current status of trial NCT03266536?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-01-09. Estimated completion is 2017-05-19.
What conditions does trial NCT03266536 study?
This clinical trial studies the following conditions: Small Intestine Bacteria.
What interventions are being tested in trial NCT03266536?
The interventions under investigation include: Western diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03266536?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03266536 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03266536's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI